Rgs19 - regulator of G-protein signaling 19 Gene

Also Known as GAIP; 2610042F04Rik

Species: Mus musculus

Gene Type: protein coding
Gene ID: 56470

About Rgs19

Chromosome 2: 181,330,212-181,335,770 reverse strand.GRCm39:CM000995.3

This gene has 12 transcripts (splice variants), 184 orthologues and 23 paralogues. Broad expression in spleen adult (RPKM 53.3), thymus adult (RPKM 37.4) and 27 other tissues.

Summary

Predicted to enable G-protein alpha-subunit binding activity. Predicted to act upstream of or within negative regulation of signal transduction. Predicted to be located in brush border; clathrin-coated vesicle; and membrane raft. Is expressed in embryo; forelimb bud; palatal shelf epithelium; and primary palate epithelium. Orthologous to human RGS19 (regulator of G protein signaling 19). [provided by Alliance of Genome Resources, Apr 2022]

Rgs19 Products (7)

mRNA Protein Name
NM_001291205.1 NP_001278134.1 regulator of G-protein signaling 19 isoform a
NM_001291206.1 NP_001278135.1 regulator of G-protein signaling 19 isoform b
NM_001291207.1 NP_001278136.1 regulator of G-protein signaling 19 isoform c
NM_001291210.1 NP_001278139.1 regulator of G-protein signaling 19 isoform e
NM_001291208.1 NP_001278137.1 regulator of G-protein signaling 19 isoform c
NM_001291209.1 NP_001278138.1 regulator of G-protein signaling 19 isoform d
NM_026446.4 NP_080722.1 regulator of G-protein signaling 19 isoform b

Gene Ontology

  • Molecular Function
Molecular Function GO Annotation Evidence References Source
enables protein binding IPI
IPI: Inferred from physical interaction
9770488 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

Rgs19 Protein Structure

RGS

RGS: cl02565 (86 - 203)

  • 0
  • 100
  • 200
  • 216 a.a.
Protein Preferred Names Protein Names

regulator of G-protein signaling 19

  • G-alpha interacting protein

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-13509 CCG-50014 Inhibitor 99.62% Unkown
HY-U00431 CCG 203769 Inhibitor 98.97% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Rgs19 NCBI NCBI:10287